Sillazze
I don’t share your concerns.
The good news is that this communication from the USPTO, dated 25 October, confirms that the NNZ-2591 patent has been allowed by the US Patent Office and is ready for issuance.
However, the equivalent of a final patent proofreading has found three minor errors that need fixing first. These all relate to “drawing deficiencies”– for example, some drawings/figure numbers have been missed or are duplicated.
As per the usual USPTO process, a deadline of two months has been given to correct these minor deficiencies, which, in my view, are the equivalent of typos. Really, a couple of days should be more than sufficient to fix the errors and return the paperwork.
What is most important, in my view, is what is written on the front page of the correspondence from the USPTO – Notice of Allowance Mailed.
- Forums
- ASX - By Stock
- NEU
- Ann: Appendix 4C - quarterly
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.07%
!
$12.96

Ann: Appendix 4C - quarterly, page-21
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.96 |
Change
-0.140(1.07%) |
Mkt cap ! $1.612B |
Open | High | Low | Value | Volume |
$13.20 | $13.36 | $12.82 | $4.627M | 354.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7585 | $12.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.03 | 3344 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7585 | 12.960 |
1 | 588 | 12.950 |
2 | 1799 | 12.910 |
2 | 3925 | 12.900 |
3 | 2813 | 12.890 |
Price($) | Vol. | No. |
---|---|---|
13.030 | 3344 | 2 |
13.050 | 1296 | 2 |
13.060 | 1291 | 1 |
13.070 | 2890 | 3 |
13.080 | 3090 | 3 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |